Table 2.
Selenoproteins involved in metastasis.
Selenoproteins | Studies | Cancer/cell | Function | Reference |
---|---|---|---|---|
TXR1 | in vitro | mammary endothelial cells | TXR1 inhibition reduces VEGF, cell migration, proliferation and tube formation | [47] |
mice | Lewis lung carcinoma cell | TXR1 inhibition reduces lung metastasis | [56] | |
in vitro | Lewis lung carcinoma cell | TXR1 inhibition reduces HGF and OPN | [56] | |
clinically | human oral squamous cell carcinoma | correlated with lymph node metastasis and with the clinical stage | [57] | |
GPX3 | in vitro | human prostate cancer cells, PC3, DU145 and LNCaP | GPX3 overexpression reduces cell invasion | [58] |
mice | human prostate cancer cells, PC3 with GPX3 overexpression | GPX3 overexpression reduces primary tumor sizes, eliminates metastasis, and promotes survival | [58] | |
GPX2 | in vitro | human colon adenocarcinoma cell, HT29 | inhibit cell migration and invasion | [59] |
SBP1 | in vitro | human colon cancer cell, HCT116 | SBP1 overexpression inhibits cell migration | [60] |
in vitro | human liver cancer cell, SMMC7721 | SBP1 reduction increases cell migration and GPX1 activity | [61] | |
Sep15 | mice | murine colon cancer cells, CT26 | Sep15 inhibition reduces lung metastasis | [62] |